The company has close links to Kyoto and Tokyo University and is co-funded by INCJ, a governmental industrial innovation organization
Megakaryon press release, August 23, 2013
Megakaryon Corp., a Tokyo-based venture, to start clinical trial of iPS-derived platelet cells in 2016